Signum Biosciences, Inc
The Science of Staying Healthy®
The Science of Staying Healthy®
Signum Biosciences, Inc. is a private biotechnology company founded in 2004 and headquartered in the United States. The company is dedicated to developing small-molecule therapeutics derived from its phosphatase platform to modulate signal transduction imbalances. Signum has established a robust IP portfolio in the area of Signal Transduction Modulators (STMs).
The company's phosphatase technology provides numerous opportunities for the development of novel pharmaceutical therapeutics. Signum has identified agents that perturb the two most central global regulatory mechanisms: G-Protein-Mediated membrane receptor signaling and Protein phosphorylation.
Moreover, Signum Biosciences has received a $1.60M grant investment on 15 November 2013. The company's slogan, "The Science of Staying Healthy®," underscores its focus on promoting well-being through its innovative products. Its offerings, including G-Protein modulators (GPMs) and Phospho-Protein modulators (PPMs), have applications in cosmetics and dietary supplements to address stressful imbalances that can be detrimental to health and well-being.
With a strong emphasis on leveraging science to support health, Signum Biosciences presents a compelling investment opportunity within the biotechnology and health care sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $1.60M | - | 15 Nov 2013 | |
| Venture Round | $4.00M | - | 25 Jul 2011 | |
| Venture Round | Unknown | 1 |
|
27 Apr 2007 |
We care about your data, and we'd love to use cookies make your experience better.
